Fenofibrate enhances the in vitro differentiation of foxp3(+) regulatory T cells in mice.

Abstract:

:Foxp3(+) regulatory T cells (Tregs) play a critical role in maintaining immune self-tolerance. Reduced number and activity of Tregs are usually found in autoimmune and inflammatory diseases, and enhancing the differentiation of Tregs may be a promising therapeutic strategy. Some reports suggested an anti-inflammatory and anti-autoimmune potential for fenofibrate, a hypolipidemic drug used worldwide, whose lipid effects are mediated by the activation of peroxisome proliferator-activated receptor α (PPARα). In the present paper, we found that fenofibrate dose-dependently increased transforming growth factor-β and interleukin-2-induced Treg differentiation in vitro, by 1.96-fold from 0 to 20 μM (12.59 ± 1.34% to 24.69 ± 3.03%, P < 0.05). Other PPARα activators, WY14643 (100 μM), gemfibrozil (50 μM), and bezafibrate (30 μM), could not enhance Treg differentiation. In addition, PPARα could not upregulate the promoter activity of the Treg-specific transcription factor Foxp3. Fenofibrate might exert its function by enhancing Smad3 phosphorylation, a critical signal in Treg differentiation, via Akt suppression. Our work reveals a new PPARα independent anti-inflammatory mechanism of fenofibrate in up-regulating mouse Treg differentiation.

journal_name

PPAR Res

journal_title

PPAR research

authors

Zhou Z,Liang Y,Gao Y,Kong W,Feng J,Wang X

doi

10.1155/2012/529035

subject

Has Abstract

pub_date

2012-01-01 00:00:00

pages

529035

eissn

1687-4757

issn

1687-4765

journal_volume

2012

pub_type

杂志文章
  • Peroxisome proliferator activated receptor ligands as regulators of airway inflammation and remodelling in chronic lung disease.

    abstract::Inflammation is a major component in the pathology of chronic lung diseases, including asthma. Anti-inflammatory treatment with corticosteroids is not effective in all patients. Thus, new therapeutic options are required to control diverse cellular functions that are currently not optimally targeted by these drugs in ...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2007/14983

    authors: Ward JE,Tan X

    更新日期:2007-01-01 00:00:00

  • The Role of PPARs in Placental Immunology: A Systematic Review of the Literature.

    abstract::Pregnancy is a state of immunotolerance, and pregnancy outcome is strongly linked to the correct activation and balancing of the maternal immune system. Besides abortion as possible result of improper early pregnancy development, other pregnancy associated conditions like preeclampsia (PE), intrauterine growth retarda...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2013/970276

    authors: Hutter S,Knabl J,Andergassen U,Jeschke U

    更新日期:2013-01-01 00:00:00

  • Peroxisome Proliferator-Activated Receptor Delta: A Conserved Director of Lipid Homeostasis through Regulation of the Oxidative Capacity of Muscle.

    abstract::The peroxisome proliferator-activated receptors (PPARs), which are ligand-inducible transcription factors expressed in a variety of tissues, have been shown to perform key roles in lipid homeostasis. In physiological situations such as fasting and physical exercise, one PPAR subtype, PPARdelta, triggers a transcriptio...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2008/172676

    authors: de Lange P,Lombardi A,Silvestri E,Goglia F,Lanni A,Moreno M

    更新日期:2008-01-01 00:00:00

  • PPARgamma: The Portrait of a Target Ally to Cancer Chemopreventive Agents.

    abstract::Peroxisome proliferator-activated receptor-gamma (PPARgamma), one of three ligand-activated transcription factors named PPAR, has been identified as a molecular target for cancer chemopreventive agents. PPARgamma was initially understood as a regulator of adipocyte differentiation and glucose homeostasis while later o...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2008/436489

    authors: Sainis I,Vareli K,Karavasilis V,Briasoulis E

    更新日期:2008-01-01 00:00:00

  • Vascular Remodeling, Oxidative Stress, and Disrupted PPARγ Expression in Rats of Long-Term Hyperhomocysteinemia with Metabolic Disturbance.

    abstract::Hyperhomocysteinemia, a risk factor for vascular disease, is associated with metabolic syndrome. Our study was aimed at exploring the effect of long-term hyperhomocysteinemia with metabolic disturbances on vascular remodeling. We also studied oxidative stress and expression of PPARγ in the coronary arteriole as a poss...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2018/6738703

    authors: Huo Y,Wu X,Ding J,Geng Y,Qiao W,Ge A,Guo C,Lv J,Bao H,Fan W

    更新日期:2018-01-15 00:00:00

  • Caffeoylquinic Acid-Rich Extract of Aster glehni F. Schmidt Ameliorates Nonalcoholic Fatty Liver through the Regulation of PPARδ and Adiponectin in ApoE KO Mice.

    abstract::Aster glehni is well known for its therapeutic properties. This study was performed to investigate the effects of A. glehni on nonalcoholic fatty liver disease (NAFLD) in atherosclerotic condition, by determining the levels of biomarkers related to lipid metabolism and inflammation in serum, liver, and adipose tissue....

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2017/3912567

    authors: Lee YJ,Jang YN,Han YM,Kim HM,Jeong JM,Son MJ,Jin CB,Kim HJ,Seo HS

    更新日期:2017-01-01 00:00:00

  • Nitrooleic Acid Attenuates Lipid Metabolic Disorders and Liver Steatosis in DOCA-Salt Hypertensive Mice.

    abstract::Nitrooleic acid (OA-NO2) is endogenous ligands for peroxisome proliferator-activated receptors. The present study was aimed at investigating the beneficial effects of OA-NO2 on the lipid metabolism and liver steatosis in deoxycorticosterone acetate- (DOCA-) salt induced hypertensive mice model. Male C57BL/6 mice were ...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2015/480348

    authors: Wang H,Sun J,Jia Z,Yang T,Xu L,Zhao B,Yu K,Wang R

    更新日期:2015-01-01 00:00:00

  • Association of PPAR Alpha Intron 7 G/C, PPAR Gamma 2 Pro12Ala, and C161T Polymorphisms with Serum Fetuin-A Concentrations.

    abstract:BACKGROUND:Both peroxisome activator proteins (PPARs) and fetuin-A play a role in lipid and glucose metabolism. AIMS:We investigated whether PPARα intron 7 G2468/C and PPARγ2 Pro12Ala and PPARγ exon 6 C161T polymorphisms are associated with serum fetuin-A concentrations. PATIENTS AND METHODS:The PPARα intron 7 G/C po...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2017/7636019

    authors: Márkus B,Vörös K,Supák D,Melczer Z,Cseh K,Kalabay L

    更新日期:2017-01-01 00:00:00

  • Therapeutic Potential of PPARγ Activation in Stroke.

    abstract::Stroke (focal cerebral ischemia) is a leading cause of death and disability among adult population. Many pathological events including inflammation and oxidative stress during the acute period contributes to the secondary neuronal death leading the neurological dysfunction after stroke. Transcriptional regulation of g...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2008/461981

    authors: Vemuganti R

    更新日期:2008-01-01 00:00:00

  • Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?

    abstract::Glioblastoma multiforme (GBM) represents one of the most frequent malignant brain tumors. Current therapies do not provide real solutions to this pathology. Their failure can be ascribed to a cell subpopulation with stem-like properties called glioma stem cells (GSCs). Therefore, new therapeutic strategies GSC-targete...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2016/7175067

    authors: Cilibrasi C,Butta V,Riva G,Bentivegna A

    更新日期:2016-01-01 00:00:00

  • Activation of PPARγ by Rosiglitazone does not negatively impact male sex steroid hormones in diabetic rats.

    abstract::Peroxisome proliferator-activated receptor gamma (PPARγ) activation decreased serum testosterone (T) in women with hyperthecosis and/or polycystic ovary syndrome and reduced the conversion of androgens to estradiol (E2) in female rats. This implies modulation of female sex steroid hormones by PPARγ. It is not clear if...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2009/101857

    authors: Mansour M,Coleman E,Dennis J,Akingbemi B,Schwartz D,Braden T,Judd R,Plaisance E,Stewart LK,Morrison E

    更新日期:2009-01-01 00:00:00

  • Inhibition of Carrageenan-Induced Cutaneous Inflammation by PPAR Agonists Is Dependent on Hepatocyte-Specific Retinoid X ReceptorAlpha.

    abstract::It has been proposed that PPAR-dependent, accelerated catabolism of proinflammatory mediators may contribute to the fast resolution of inflammation. Because retinoid X receptors are obligate heterodimer partners of PPARs, we investigated the impact of deleting hepatocyte-specific RXRalpha on the antiedema effect of PP...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/PPAR/2006/96341

    authors: Wan YJ,Badr MZ

    更新日期:2006-01-01 00:00:00

  • Stimulation of Alpha1-Adrenergic Receptor Ameliorates Cellular Functions of Multiorgans beyond Vasomotion through PPARδ.

    abstract::Cells can shift their metabolism between glycolysis and oxidative phosphorylation to enact their cell fate program in response to external signals. Widely distributed α1-adrenergic receptors (ARs) are physiologically stimulated during exercise, were reported to associate with the activating energetic AMPK pathway, and...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2020/3785137

    authors: Lee YJ,Kim HS,Seo HS,Na JO,Jang YN,Han YM,Kim HM

    更新日期:2020-02-01 00:00:00

  • PPAR-gamma Signaling Crosstalk in Mesenchymal Stem Cells.

    abstract::Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) is a member of the nuclear receptor (NR) superfamily of ligand-activated transcriptional factors. Among other functions, PPAR-gamma acts as a key regulator of the adipogenesis. Since several cytokines (IL-1, TNF-alpha, TGF-beta) had been known to inhibit ad...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2010/341671

    authors: Takada I,Kouzmenko AP,Kato S

    更新日期:2010-01-01 00:00:00

  • Diet Modifies Pioglitazone's Influence on Hepatic PPARγ-Regulated Mitochondrial Gene Expression.

    abstract::Pioglitazone (Pio) is a thiazolidinedione (TZD) insulin-sensitizing drug whose effects result predominantly from its modulation of the transcriptional activity of peroxisome proliferator-activated-receptor-gamma (PPARγ). Pio is used to treat human insulin-resistant diabetes and also frequently considered for treatment...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2020/3817573

    authors: Kulkarni S,Huang J,Tycksen E,Cliften PF,Rudnick DA

    更新日期:2020-09-10 00:00:00

  • The Role of PPARgamma Receptors and Leukotriene B(4) Receptors in Mediating the Effects of LY293111 in Pancreatic Cancer.

    abstract::Pancreatic cancer is a devastating disease in which current therapies are inadequate. Separate lines of research have identified the 5-lipoxygenase/leukotriene B(4) receptor pathway and the PPARgamma pathway as potential targets for prevention or treatment of this disease. LY293111 was originally designed as a potent ...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2008/827096

    authors: Adrian TE,Hennig R,Friess H,Ding X

    更新日期:2008-01-01 00:00:00

  • Combined Rosiglitazone and Forskolin Have Neuroprotective Effects in SD Rats after Spinal Cord Injury.

    abstract::The peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist rosiglitazone inhibits NF-κB expression and endogenous neural stem cell differentiation into neurons and reduces the inflammatory cascade after spinal cord injury (SCI). The aim of this study was to explore the mechanisms underlying rosiglitazone-me...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2018/3897478

    authors: Meng QQ,Lei W,Chen H,Feng ZC,Hu LQ,Zhang XL,Li S

    更新日期:2018-06-21 00:00:00

  • Potential Therapeutic Use of PPARgamma-Programed Human Monocyte-Derived Dendritic Cells in Cancer Vaccination Therapy.

    abstract::Dendritic cells (DCs) can regulate all elements of the immune system, and therefore are an ideal target for vaccination. During the last two decades, as a result of extensive research, DCs became the primary target of antitumor vaccination as well. A critical issue of antitumor vaccination is the phenotype of the dend...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2008/473804

    authors: Gyöngyösi A,Nagy L

    更新日期:2008-01-01 00:00:00

  • Changes in the 24 h Rhythmicity of Liver PPARs and Peroxisomal Markers When Feeding Is Restricted to Two Daytime Hours.

    abstract::Restricted feeding (RF) during daytime is associated with anticipatory activity before feeding, marked hyperphagia after mealtime, adjustments in hepatic metabolism, and the expression of a food-entrained oscillator (FEO). 24 h rhythmicity of liver PPARα, β, and γ, peroxisomal markers (PMP70, AOX, and catalase), and f...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2011/261584

    authors: Rivera-Zavala JB,Báez-Ruiz A,Díaz-Muñoz M

    更新日期:2011-01-01 00:00:00

  • The Genetic Basis of the Polycystic Ovary Syndrome: A Literature Review Including Discussion of PPAR-gamma.

    abstract::Polycystic ovary syndrome (PCOS) is the most common endocrine disorder of the women of reproductive age. Familial clustering of PCOS has been consistently reported suggesting that genetic factors play a role in the development of the syndrome although PCOS cases do not exhibit a clear pattern of Mendelian inheritance....

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2007/49109

    authors: Unluturk U,Harmanci A,Kocaefe C,Yildiz BO

    更新日期:2007-01-01 00:00:00

  • PPAR-α Agonist Fenofibrate Decreased Serum Irisin Levels in Type 2 Diabetes Patients with Hypertriglyceridemia.

    abstract::Irisin is related to insulin resistance and metabolic disorders. The physiologic effects of irisin are partially mediated through peroxisome proliferator-activated receptor-α (PPAR-α). We investigated the effect of fenofibrate, a PPAR-α agonist, on serum irisin in type 2 diabetes patients with hypertriglyceridemia. Th...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2015/924131

    authors: Feng X,Gao X,Jia Y,Zhang H,Pan Q,Yao Z,Yang N,Liu J,Xu Y,Wang G,Yang X

    更新日期:2015-01-01 00:00:00

  • Phthalate-Induced Liver Protection against Deleterious Effects of the Th1 Response: A Potentially Serious Health Hazard.

    abstract::Infection with Mycobacterium tuberculosis (TB) induces pulmonary immunopathology mediated by classical Th1 type of acquired immunity with hepatic involvement in up to 80% of disseminated cases. Since PPAR agonists cause immune responses characterized by a decrease in the secretion of Th1 cytokines, we investigated the...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2007/49671

    authors: Badr MZ,Shnyra A,Zoubine M,Norkin M,Herndon B,Quinn T,Miranda RN,Cunningham ML,Molteni A

    更新日期:2007-01-01 00:00:00

  • PPARs, Cardiovascular Metabolism, and Function: Near- or Far-from-Equilibrium Pathways.

    abstract::Peroxisome proliferator-activated receptors (PPAR alpha, beta/delta and gamma) play a key role in metabolic regulatory processes and gene regulation of cellular metabolism, particularly in the cardiovascular system. Moreover, PPARs have various extra metabolic roles, in circadian rhythms, inflammation and oxidative st...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2010/783273

    authors: Lecarpentier Y,Claes V,Hébert JL

    更新日期:2010-01-01 00:00:00

  • 15-Deoxy-Δ(12,14)-prostaglandin J2 Induces Apoptosis and Upregulates SOCS3 in Human Thyroid Cancer Cells.

    abstract::The cyclopentenone prostaglandin 15-deoxy-Δ(12,14)-prostaglandin J2 (15d-PGJ2) is a natural ligand of peroxisome proliferator-activated receptor gamma (PPAR-γ) and a potential mediator of apoptosis in cancer cells. In the present study, we evaluated the effect of 15d-PGJ2 in human thyroid papillary carcinoma cells (TP...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2016/4106297

    authors: Trindade-da-Silva CA,Reis CF,Vecchi L,Napimoga MH,Sperandio M,Matias Colombo BF,Alves PT,Ward LS,Ueira-Vieira C,Goulart LR

    更新日期:2016-01-01 00:00:00

  • Activated PPARgamma Targets Surface and Intracellular Signals That Inhibit the Proliferation of Lung Carcinoma Cells.

    abstract::Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors belonging to the nuclear hormone receptor superfamily. Their discovery in the 1990s provided insights into the cellular mechanisms involved in the control of energy homeostasis, the regulation of cell differentiation, prolif...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2008/254108

    authors: Han SW,Roman J

    更新日期:2008-01-01 00:00:00

  • Homocysteine and Hypertension in Diabetes: Does PPARgamma Have a Regulatory Role?

    abstract::Dysfunction of macro- and microvessels is a major cause of morbidity and mortality in patients with cardio-renovascular diseases such as atherosclerosis, hypertension, and diabetes. Renal failure and impairment of renal function due to vasoconstriction of the glomerular arteriole in diabetic nephropathy leads to renal...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2010/806538

    authors: Sen U,Tyagi SC

    更新日期:2010-01-01 00:00:00

  • Inhibitors of Fatty Acid Synthesis Induce PPAR α -Regulated Fatty Acid β -Oxidative Genes: Synergistic Roles of L-FABP and Glucose.

    abstract::While TOFA (acetyl CoA carboxylase inhibitor) and C75 (fatty acid synthase inhibitor) prevent lipid accumulation by inhibiting fatty acid synthesis, the mechanism of action is not simply accounted for by inhibition of the enzymes alone. Liver fatty acid binding protein (L-FABP), a mediator of long chain fatty acid sig...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2013/865604

    authors: Huang H,McIntosh AL,Martin GG,Petrescu AD,Landrock KK,Landrock D,Kier AB,Schroeder F

    更新日期:2013-01-01 00:00:00

  • Fimasartan Ameliorates Nonalcoholic Fatty Liver Disease through PPARδ Regulation in Hyperlipidemic and Hypertensive Conditions.

    abstract::To investigate the effects of fimasartan on nonalcoholic fatty liver disease in hyperlipidemic and hypertensive conditions, the levels of biomarkers related to fatty acid metabolism were determined in HepG2 and differentiated 3T3-L1 cells treated by high fatty acid and liver and visceral fat tissue samples of spontane...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2017/8048720

    authors: Lee YJ,Jang YN,Han YM,Kim HM,Jeong JM,Seo HS

    更新日期:2017-01-01 00:00:00

  • Commonalities in the Association between PPARG and Vitamin D Related with Obesity and Carcinogenesis.

    abstract::The PPAR nuclear receptor family has acquired great relevance in the last decade, which is formed by three different isoforms (PPARα, PPARβ/δ, and PPAR ϒ). Those nuclear receptors are members of the steroid receptor superfamily which take part in essential metabolic and life-sustaining actions. Specifically, PPARG has...

    journal_title:PPAR research

    pub_type: 杂志文章,评审

    doi:10.1155/2016/2308249

    authors: Bandera Merchan B,Tinahones FJ,Macías-González M

    更新日期:2016-01-01 00:00:00

  • Structural Development Studies of Subtype-Selective Ligands for Peroxisome Proliferator-Activated Receptors (PPARs) Based on the 3,4-Disubstituted Phenylpropanoic Acid Scaffold as a Versatile Template.

    abstract::Improvements in our understanding of the functions of the nuclear receptor peroxisome proliferator-activated receptor (PPAR) subtypes as pleiotropic regulators of biological responses, including lipid, lipoprotein, glucose homeostasis, inflammation, differentiation and proliferation of various cancer cells, and memory...

    journal_title:PPAR research

    pub_type: 杂志文章

    doi:10.1155/2008/689859

    authors: Miyachi H,Hashimoto Y

    更新日期:2008-01-01 00:00:00